Targovax ASA: The board of directors of Oslo Stock Exchange approves transfer of Targovax ASA to the main list
Reference is made to the stock exchange announcement made on 17 March 2017 regarding Targovax ASA's ("Targovax" or the "Company") resolution to apply for a transfer of the listing of the Company's shares from Oslo Axess to the main list on Oslo Stock Exchange.
The board of directors of the Oslo Stock Exchange has today approved Targovax for listing on the Oslo Stock Exchange. The first day of trading on the main list will be Thursday 23 March 2017. The CEO of Targovax, Øystein Soug, will ring the bell at the start of trading on the Oslo Stock Exchange at 09:00 hours CET.
For further information, please contact:
Renate Birkeli, Investor Relations
Phone: +47 922 61 624
Email: renate.birkeli@targovax.com
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Targovax ASA via GlobeNewswire
Upcoming Life Sciences Events
- April 2024
- Pharma-Biotech Product & Company Valuation - An Introductory
- Basel: Swiss Biotech Day 2024
- London: BioTrinity 2024
Latest company news
There are currently no news available for this portal